Диссертация (Диагностика и определение прогноза при синдроме ДКМП - роль мультиспиральной компьютерной томографии сердца в сопоставлении с биопсией миокарда), страница 17

Dambrin G, Laissy JP, Serfaty JM, Caussin C, Lancelin B, Paul JF.Diagnostic value of ECG-gated multidetector computed tomography in theearly phase of suspected acute myocarditis. A preliminary comparative studywith cardiac MRI. Eur Radiol. 2007; 17(2):331-338.48. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA.Active myocarditis in the spectrum of acute dilated cardiomyopathies.Clinical features, histologic correlates, and clinical outcome. N Engl J Med.1985; 312(14):885-90. DOI: 10.1056/NEJM198504043121404.49.

Dec GW, Palacios I, Yasuda T, et al. Antimyosin antibody cardiac imaging:its role in the diagnosis of myocarditis. J Am Coll Cardiol. 1990; 16(1):97–104. https://doi.org/10.1016/0735-1097(90)90463-Y.50. Deckers JW, Hare JM, Baughman KL. Complications of transvenous rightventricular endomyocardial biopsy in adult patients with cardiomyopathy: aseven-year survey of 546 consecutive diagnostic procedures in a tertiaryreferral center. J Am Coll Cardiol. 1992; 19: 43–47.51.

Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J.2008; 29(17):2073-82. DOI: 10.1093/eurheartj/ehn296.52. Desai D, Moodley J, Naidoo D. Peripartum cardiomyopathy: experiences atKing Edward VIII Hospital, Durban, South Africa and a review of theliterature.TropDoct.1995;25(3):118-23.DOI:10.1177/004947559502500310.53.

Disertori M, Rigoni M, Pace N, Casolo G, Masè M, Gonzini L, Lucci D,Nollo G, Ravelli F. Myocardial Fibrosis Assessment by LGE Is a PowerfulPredictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LVDysfunction: A Meta-Analysis. JACC Cardiovasc Imaging. 2016; 9(9):10461055. doi: 10.1016/j.jcmg.2016.01.033.10554. Ehara M., Surmely J. F., Kawai M. et al.

Diagnostic accuracy of 64-slicecomputed tomography for detecting angiographically significant coronaryartery stenosis in an unselected consecutive patient population: comparisonwith conventional invasive angiography. Circ. J. 2006; 70(5):564–571.55. Elliott P., Andersson B., Arbustini E., et al. Classification of thecardiomyopathies: a position statement from the European Society ofCardiology Working Group on Myocardial and Pericardial Diseases. EurHeart J.

2008; 29: 270-276. https://doi.org/10.1093/eurheartj/ehm342.56. Elliott P, Charron P, Blanes JR, Tavazzi L, Tendera M, Konté M, Laroche C,Maggioni AP; EORP Cardiomyopathy Registry Pilot Investigators. EuropeanCardiomyopathy Pilot Registry: EURObservational Research Programme ofthe European Society of Cardiology.

Eur Heart J. 2016; 37(2):164-73. doi:10.1093/eurheartj/ehv497.57. Emery AE. Emery-Dreifuss muscular dystrophy – a 40 year retrospective.Neuromuscul Disord. 2000; 10(4-5):228-232.58. Eriksson U, Penninger JM, Kopf M. Mechanisms of autoimmune heartdisease.DrugDiscovToday.2004;1:283–288.DOI:10.1016/j.ddmec.2004.11.011.59. Ethan R Ellis, Mark E Josephson. What About Tachycardia-inducedCardiomyopathy? Arrhythm Electrophysiol Rev. 2013; 2(2): 82–90. doi:10.15420/aer.2013.2.2.82.60. Fauchier L., Babuty D., Poret P., et al. Comparison of long-term outcome ofalcoholic and idiopathic dilated cardiomyopathy.

Eur Heart J. 2000; 21:306314. DOI: 10.1053/euhj.1999.1761.61. Felker GM, Hu W, Hare JW, Hruban RH, Baughman KL, Kasper EK. Thespectrum of dilated cardiomyopathy. The Johns Hopkins experience in 1278patients. Medicine. 1999; 78: 270-283. DOI: 10.1097/00005792-19990700000005.10662. Felker GM, Thompson RE, Hare JM et al. Underlying causes and long-termsurvival in patients with initially unexplained cardiomyopathy. N Engl J Med.2000; 342:1077–1084.

DOI: 10.1056/NEJM200004133421502.63. Francone M, Chimenti C, Galea N, Scopelliti F, Verardo R, Galea R,Carbone I, Catalano C, Fedele F, Frustaci A. CMR sensitivity varies withclinical presentation and extent of cell necrosis in biopsy-proven acutemyocarditis.JACCCardiovascImaging.2014;7(3):254-63.doi:10.1016/j.jcmg.2013.10.011.64. Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy foractive lymphocytic myocarditis: virological and immunologic profile ofresponders versus nonresponders. Circulation.

2003; 107(6):857–863.65. Gaztanaga J, Paruchuri V, Elias E, Wilner J, Islam S, Sawit S, VilesGonzalez J, Sanz J, Garcia MJ. Prognostic Value of Late GadoliniumEnhancement in Nonischemic Cardiomyopathy. Am J Cardiol. 2016;118(7):1063-8. doi:10.1016/j.amjcard.2016.06.059.66. George A, Figueredo VM. Alcoholic cardiomyopathy: a review. J Card Fail.2011; 17:844–849.67.

Goodwin J.F., Oakley C.M. The cardiomyopathies. Br Heart J. 1972; 34:545-552.68. Gregorio CC, Granzier H, Sorimachi H, Labeit S. Muscle assembly: a titanicachievement? Curr Opin Cell Biol. 1999; 11(1):18-25.69. Guillaume Baudry, Claire Bouleti, Bernard Lung, Gregory Ducrocq, et al.Cardiac spectral CT scan to diagnose acute myocarditis: a new imagingtechnique. Archives of Cardiovascular Diseases Supplements. 2012; 8(3):252.70. Guo W, Schafer S, Greaser ML, Radke MH et al.

RBM20, a gene forhereditary cardiomyopathy, regulates titin splicing. Nat Med. 2012;18(5):766-73. DOI: 10.1038/nm.2693.10771. Haas J , Frese KS, Peil B, Kloos W, Keller A et al. Atlas of the clinicalgenetics of human dilated cardiomyopathy. Eur Heart J. 2015; 36:1123–1135a.72. Hazebroek M., Dennert R., Heymans S. Idiopathic dilated cardiomyopathy:possible triggers and treatment strategies. Neth Heart J.

2012; 20(7-8): 332–335. doi: 10.1007/s12471-012-0285-7.73. Herman DS, Lam L, Taylor MR, Wang L et al. Truncations of titin causingdilated cardiomyopathy. N Engl J Med. 2012; 366(7):619-28. DOI:10.1056/NEJMoa1110186.74. Herskowitz A, Campbell S, Deckers J et al.

Demographic features andprevalence of idiopathic myocarditis in patients undergoing endomyocardialbiopsy. Am J Cardiol. 1993; 71:982–986. DOI: https://doi.org/10.1016/00029149(93)90918-3.75. Hilfiker-Kleiner D, Sliwa K. Review Pathophysiology and epidemiology ofperipartum cardiomyopathy.NatRevCardiol.2014;11(6):364-70.doi:10.1038/nrcardio.2014.37.76. Hjalmarson A., Fu M., Mobini R.. Who are the enemies? Inflammation andautoimmune mechanisms. European Heart Journal Supplements. 2002;4:G27–G32. https://doi.org/10.1016/S1520-765X(02)90087-8.77. Homma S, Iwasaki M, Shelton GD, Engvall E, Reed JC, Takayama S.

BAG3deficiency results in fulminant myopathy and early lethality. Am J Pathol.2006; 169(3):761-73. DOI: 10.2353/ajpath.2006.060250.78. Hyun-Young Park. Hereditary Dilated Cardiomyopathy: Recent Advances inGenetic Diagnostics. Korean Circ J. 2017; 47(3): 291–298. doi:10.4070/kcj.2016.0017.79. Jay W Mason. Myocarditis and dilated cardiomyopathy: An inflammatorylink.CardiovascularResearch.https://doi.org/10.1016/S0008-6363(03)00437-1.2003;60(1):5–10.10880. Kristopher W. Cummings, Sanjeev Bhalla, Cylen Javidan-Nejad, Andrew J.Bierhals, Fernando R.

Gutierrez, Pamela K. Woodard. A Pattern-basedApproach to Assessment of Delayed Enhancement in NonischemicCardiomyopathy at MR Imaging. RadioGraphics. 2009; 29(1):89-103.https://doi.org/10.1148/rg.291085052.81. Kühl U, Schultheiss HP. Viral myocarditis. Swiss Med Wkly. 2014;144:w14010. doi: 10.4414/smw.2014.14010.82.

Lakdawala NK, Funke BH, Baxter S, Cirino AL et al. Genetic testing fordilated cardiomyopathy in clinical practice. J Card Fail. 2012; 18(4):296-303.DOI: 10.1016/j.cardfail.2012.01.013.83. Lee HJ, Im DJ, Youn JC, Chang S, et al. Myocardial Extracellular VolumeFraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT inNonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MRImaging. Radiology. 2016; 280(1):49-57. doi: 10.1148/radiol.2016151289.84. Leslie T. Cooper, Kenneth L. Baughman, Arthur M. Feldman, AndreaFrustaci, et al. The Role of Endomyocardial Biopsy in the Management ofCardiovascular Disease. A Scientific Statement From the American HeartAssociation, the American College of Cardiology, and the European SocietyofCardiology.Circulation.2007;116:2216-2233.https://doi.org/10.1161/CIRCULATIONAHA.107.186093.85.

Leuschner F, Katus HA, Kaya Z. Autoimmune myocarditis: Past, present andfuture.JournalofAutoimmunity.2009;33:282–289.doi:10.1016/j.jaut.2009.07.009.86. Lima J.A., Judd R., Bazille A. et al.Regional heterogenity of humanmyocardial infarcts demonstrated by contrast-enhanced MRI:mechanisms.Circulation.1995;potential92(5):1117-1125.https://doi.org/10.1161/01.CIR.92.5.1117.87. Lurz P, Luecke C, Eitel I, Föhrenbach F, Frank C, Grothoff M, de Waha S,Rommel KP, Lurz JA, Klingel K, Kandolf R, Schuler G, Thiele H, Gutberlet109M.

Comprehensive Cardiac Magnetic Resonance Imaging in Patients WithSuspected Myocarditis: The MyoRacer-Trial. J Am Coll Cardiol. 2016;67(15):1800-11. doi: 10.1016/j.jacc.2016.02.013.88. Magnani J.W., Dec G.W. Myocarditis: Current Trends in Diagnosis andTreatment.Circulation.2006;113(6):876-890.DOI:10.1161/CIRCULATIONAHA.105.584532.89.

Mahmaljy H, Bhimji S. Cardiomyopathy, Dilated. Treasure Island (FL):StatPearls Publishing; 2017 Jun.90. Maisch B, Portig I, Ristic A, Hufnagel G, Pankuweit S. Herz. Definition ofinflammatory cardiomyopathy (myocarditis): on the way to consensus. Astatus report. 2000; 25(3):200-9.91. Maisch B, Ristić AD, Hufnagel G, Pankuweit S. Pathophysiology of viralmyocarditis: the role of humoral immune response. Cardiovasc Pathol. 2002;11(2):112-22.92.

Maisel AS, Krishnaswamy P, Nowak RM, McCord J, et al. Rapidmeasurement of B-type natriuretic peptide in the emergency diagnosis ofheartfailure.NEnglJMed.2002;347(3):161-167.DOI:10.1056/NEJMoa020233.93. Matthias G. Friedrich, François Marcotte.

Cardiac Magnetic ResonanceAssessment of Myocarditis. Circ Cardiovasc Imaging. 2013; 6:833-839. DOI:10.1161/CIRCIMAGING.113.000416.94. Matthias G. Friedrich, Udo Sechtem, Jeanette Schulz-Menger, GodtfredHolmvang, et al. Cardiovascular Magnetic Resonance in Myocarditis: AJACC White Paper. J Am Coll Cardiol. 2009; 53(17):1475–1487.

doi:10.1016/j.jacc.2009.02.007.95. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions andclassification of the cardiomyopathies: an American Heart AssociationScientific Statement from the Council on Clinical Cardiology, Heart Failureand Transplantation Committee; Quality of Care and Outcomes Research and110Functional Genomics and Translational Biology Interdisciplinary WorkingGroups; and Council on Epidemiology and Prevention. Circulation. 2006;113: 1807-1816. https://doi.org/10.1161/CIRCULATIONAHA.106.17428796. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM,Billingham ME, Moon TE.